Cellebrite DI Ltd. operates in the technology sector within the digital intelligence and forensic data analysis industry. The company provides software and solutions designed to extract, analyze and manage digital data for investigative and compliance purposes.

Its platform is widely used by government agencies and organizations that require structured digital evidence and advanced analytics capabilities.

Its main areas of activity include:

• Digital data extraction from mobile devices and systems.
• Forensic analysis and investigation platforms.
• Data analytics and evidence correlation tools.
• Intelligence solutions for law enforcement and enterprises.
• Training, support and software maintenance services.

The company operates globally, with a strong presence in the United States, Europe, Asia-Pacific, Latin America, the Middle East and Africa, serving public safety agencies, corporate clients and financial institutions.

Cellebrite’s solutions support digital investigations, compliance processes and intelligence operations in environments with increasing data complexity.

Industry dynamics affecting the company include the growth of digital data, rising cybercrime, regulatory requirements, demand for investigative efficiency and competition from other digital forensics providers.

Shares of Cellebrite DI Ltd. trade on the Nasdaq under the ticker CLBT.

History and Development

Cellebrite was founded in 1999 in Israel, initially focused on developing technologies for mobile device management during the early expansion of digital communications.

In its early years, the company faced challenges related to rapid technological evolution, requiring continuous adaptation to new devices, operating systems and data formats. The company gained traction as its solutions were adopted by law enforcement and investigative agencies across multiple countries.

Over time, Cellebrite expanded its portfolio to include advanced analytics, digital intelligence platforms and enterprise-focused solutions, broadening its customer base beyond the public sector. A key milestone was its initial public offering (IPO) in 2021, which supported further investment in research, product development and global expansion.

In recent years, the company has benefited from increasing demand for digital investigation tools, driven by the growth of data volumes and the complexity of digital environments.

Additional Information

Cellebrite DI (United States) is listed on the Nasdaq and has a market capitalization of $2.90 billion, with shareholders equity totaling $538.10 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Cellebrite DI reported $514.29 million in revenue, generating net income of $58.76 million.

Key financial metrics include a P/E ratio of 49.43, a price-to-book (P/B) ratio of 5.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLBT.